Suhair Sh. Al-Siraj

Suhair Sh. Al-Siraj

Auto-generated profile, based on publicly available information

Suhair Sh. Al-Siraj

Department of Biology, College of Science, Mustansiriyah University, Baghdad 10052, Iraq

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Environmental Health Perspectives
Verified
Journal Article
Closed access
MFMagdalena Fandiño-Del-Rio
Magdalena Fandiño-Del-Rio
JKJosiah L. Kephart
Josiah L. Kephart
KWKendra Williams
Kendra Williams
TSTimothy Shade
Timothy Shade
TATemi Adekunle
Temi Adekunle
CICardiopulmonary outcomes and Household Air Pollution (CHAP) Trial Investigators
Cardiopulmonary outcomes and Household Air Pollution (CHAP) Trial Investigators

1 January 2026 in Biomedical and Biopharmaceutical Research
Verified
Journal Article
Open access
NMNada Zaki Mahdi
Nada Zaki Mahdi
AAAmina Mohammed Ali
Amina Mohammed Ali
SASuhair Sh. Al-Siraj
Suhair Sh. Al-Siraj
TATemilade Adekunle
Temilade Adekunle
Rebeca AndréRebeca André
Rebeca André
MLMaha F. Lofty
Maha F. Lofty
Cancer and diabetes are prevalent global disorders that affect large segments of the population and exert substantial burdens on national economies, quality of life, and morbidity and mortality indicators. In this study, the therapeutic potential of methionine gamma-lyase (MGL) was investigated as a candidate anticancer, antidiabetic, and anti-inflammatory agent. MGL was produced following the isolation of Streptomyces maritimus from soil, and both starch nitrate agar and a modified formulation were employed as differential and selective media to support biochemical identification of the bacterial isolates. Enzyme purification was achieved through sequential application of acetone precipitation, ammonium sulfate fractionation, gel filtration chromatography, and ion-exchange chromatography, yielding a substantially enriched protein as confirmed by SDS-PAGE analysis. The biological activities of MGL were assessed using an MTT cytotoxicity assay, an in vitro α-amylase inhibitory assay, and an in vitro anti-inflammatory assay to determine its suitability as an effective and cost-efficient alternative to commonly used protocols. The findings demonstrated that only 14% of Hep-2 cells remained viable at the highest concentration of MGL extract, erythrocyte hemolysis inhibition reached 29% at the lowest concentration tested, and the enzyme exhibited an IC₅₀ of 78 µg mL-1 for α-amylase inhibition, suggesting a promising capacity to attenuate postprandial blood glucose excursions in individuals with diabetes.